F2RL2 and breast carcinoma: In breast cancer, F2RL2 promotes tumor growth and metastasis by activating the thrombin signaling pathway, whereas in ovarian cancer, it accelerates tumor progression by modulating immune evasion mechanisms, such as modulating immune cell infiltration [28].